Altria Group Inc. Chief Executive Marty Barrington is retiring and will be replaced by another 25-year company veteran. Mr. Barrington, who has held the top post for six years, will retire in May after a quarter of a century with the tobacco company, Altria said Thursday. His replacement is Howard Willard, 54, the company's current operating chief and former finance chief.
ApidraÂ® (insulin glulisine) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes in adults. It is a rapid-acting insulin used to help control the spike in blood sugar levels that occurs after meals. It is typically used in combination with a long-acting insulin.
Alpha-glucosidase inhibitor. Alpha-glucosidase inhibitors are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar). Carbohydrates are normally converted into simple sugars (monosaccharides), which can be absorbed through the intestine. Hence, alpha-glucosidase inhibitors reduce the impact of carbohydrates on blood sugar.